Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - SHORT-TERM INVESTMENTS
Short-term Investments ALNY - Alnylam Pharmaceuticals, Inc.
1.63 B
LAST VALUE
0.34%
2 YEAR CAGR
19.63%
5 YEAR CAGR
23.78%
10 YEAR CAGR